Omicron BA.5 Subvariant Provokes the Fifth COVID-19 Wave in Mexico: Closer to the End of This Pandemic

被引：1
|
作者：
De La Cruz-Hernandez, Sergio Isaac [1 ]
Alvarez-Contreras, Ana Karen [2 ]
机构：
[1] Minist Hlth Mexico, Dept Virol, Inst Epidemiol Diag & Reference InDRE, Mexico City, Mexico
[2] Natl Polytech Inst, Natl Sch Biol Sci, Dept Microbiol, Mexico City, Mexico
来源：
DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS | 2023年 / 17卷
关键词：
COVID-19; Mexico; Omicron subvariant BA.5; SARS-CoV-2; vaccinated people; VARIANT;
D O I：
10.1017/dmp.2023.14
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Does the COVID-19 XBB Omicron subvariant signal the beginning of the end of the pandemic?
    Ngiam, Jinghao Nicholas
    Al-Mubaarak, Abdurrahmaan
    Maurer-Stroh, Sebastian
    Tambyah, Paul Anantharajah
    SINGAPORE MEDICAL JOURNAL, 2024, 65 (12) : 658 - 664
  • [2] Omicron Variant in Mexico: the Fourth COVID-19 Wave
    De La Cruz-Hernandez, Sergio Isaac
    Alvarez-Contreras, Ana Karen
    DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS, 2022,
  • [3] The End of the COVID-19 Pandemic in Mexico: Omicron Sublineages BQ.1 and XBB Trigger the Sixth Wave of Infections
    De La Cruz-Hernandez, Sergio Isaac
    Alvarez-Contreras, Ana Karen
    DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS, 2024, 18
  • [4] Comparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults
    Kopel, Hagit
    Nguyen, Van Hung
    Boileau, Catherine
    Bogdanov, Alina
    Winer, Isabelle
    Ducruet, Thierry
    Zeng, Ni
    Bonafede, Mac
    Esposito, Daina B.
    Martin, David
    Rosen, Andrew
    van de Velde, Nicolas
    Vermund, Sten H.
    Gravenstein, Stefan
    Mansi, James A.
    VACCINES, 2023, 11 (11)
  • [5] COVID-19 hospitalisations in a tertiary health service during the Omicron subvariant wave
    Wanigaratne, Alysha Y.
    Baptista, Mohana
    Langham, Freya
    Stripp, Andrew
    Stuart, Rhonda L.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2024, 48 (04)
  • [6] SARS-CoV-2 Omicron (BA.4, BA.5) variant: Lessons learned from a new variant during the COVID-19 pandemic
    Erabi, Gisou
    Faridzadeh, Arezoo
    Parvin, Ali
    Deravi, Niloofar
    Rahmanian, Mohammad
    Fathi, Mobina
    Aleebrahim-Dehkordi, Elahe
    Rezaei, Nima
    HEALTH SCIENCE REPORTS, 2024, 7 (02)
  • [7] Heterologous booster vaccines reduce severity and mortality in COVID-19 during BA.2 and BA.4/BA.5 omicron predominance in Thailand
    Intawong, Kannikar
    Chariyalertsak, Suwat
    Chalom, Kittipan
    Wonghirundecha, Thanachol
    Kowatcharakul, Woravut
    Thongprachum, Aksara
    Chotirosniramit, Narain
    Noppakun, Kajohnsak
    Khwanngern, Krit
    Teacharak, Worachet
    Piamanant, Prapon
    Khammawan, Pimpinan
    Iamsirithaworng, Sopon
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2023, 56 (06) : 1178 - 1186
  • [8] Estimation of mRNA COVID-19 Vaccination Effectiveness in Tokyo for Omicron Variants BA.2 and BA.5: Effect of Social Behavior
    Kodera, Sachiko
    Niimi, Yuki
    Rashed, Essam A.
    Yoshinaga, Naoki
    Toyoda, Masashi
    Hirata, Akimasa
    VACCINES, 2022, 10 (11)
  • [9] Effect of Paxlovid in COVID-19 treatment during the periods of SARS-CoV-2 Omicron BA.5 and BN.1 subvariant dominance in the Republic of Korea: a retrospective cohort study
    Kim, Dong-Hwi
    Yoo, Min-Gyu
    Kim, Na-Young
    Choi, So Young
    Jang, Minjeong
    An, Misuk
    Jeong, Se-Jin
    Kim, Jungyeon
    OSONG PUBLIC HEALTH AND RESEARCH PERSPECTIVES, 2024, 15 (02) : 137 - 149
  • [10] Characteristics and outcomes of COVID-19 patients during the BA.5 omicron wave in Tehran, Iran: a prospective observational study (vol 23, 237, 2023)
    Salehi, Mohammadreza
    Khaneshan, Arezoo Salami
    Farahani, Abbas Shakoori
    Doomanlou, Mahsa
    Arabzadeh, Mohammad
    Sobati, Abolfazl
    Farhadi, Kousha
    Fattahi, Reza
    Mohammadnejad, Esmaeil
    Abdoli, Asghar
    Zebardast, Jayran
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
12345